Current Smoking, Smoking Cessation, and the Risk of Sudden Cardiac Death in Patients With Coronary Artery Disease

Archives of Internal Medicine

Volumn 163, Issue 19, 2003, Pages 2301-2305

  Goldenberg, Ilan ^a   Jonas, Michael ^a   Tenenbaum, Alexander ^a   Boyko, Valentina ^a   Matetzky, Shlomi ^a   Shotan, Avraham ^a   Behar, Solomon ^a   Reicher Reiss, Henrietta ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SUDDEN DEATH;

AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS; SMOKING CESSATION;

EID: 0142150187     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.19.2301     Document Type: Article

References (28)

1. Wilhelmsen I, Wedel H, Tibbin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973;48:950-958.
2. Schlant RO, Forman S, Stamler J, Canner PL, for the Coronary Drug Project Research Group. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men: the 5-year findings of the Coronary Drug Project. Circulation. 1982;66:401-414.
3. Sugishi M, Faminaro T. Cigarette smoking is a major risk for coronary spasm. Circulation. 1993;87:76-79.
4. Slone D, Shapiro S, Rosenberg L, et al. Relation of cigarette smoking to myocardial infarction in young women. N Engl J Med. 1978;298:1273-1276.
5. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation. 1996;93:2033-2036.
6. Salomon JT. Stopping smoking and long-term mortality after myocardial infarction. Br Heart J 1980;43:463-469.
7. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 1985;313:1511-1514.
8. Gordon T, Kamel WB, McGer D. Death and coronary attacks in men after giving up cigarrete smoking: a report from the Framingham Study. Lancet. 1974;2:1345-1348.
9. Kannel WB, McGee DL, Schatzkin A. An epidemiological perspective of sudden death: 26-year follow-up in the Framingham Study. Drugs. 1984;28:1-16.
10. Schatzkin A, Cupples LA, Heeren T, Morelock S, Kannel WB. Sudden death in the Framingham Heart Study: differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol. 1984;120:888-899.
11. Wannamethee G, Shaper AG, Macfarlane W, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995;91:1749-1756.
12. de Vreede-Swagemakers JJ, Gorgels AP, Weijenberg MP, et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol. 1999;52:601-607.
13. Cardiac Arrhythmia Suppression Trial (CAST) Investigators, Peters RW, Brooks MM, Todd L, Liebson PR, Wilhelmsen L. Smoking cessation and arrhythmic death: the CAST experience. J Am Coll Cardiol. 1995;26:1287-1292.
14. Hallstorm AP, Cobb LA, Ray R. Smoking is a risk factor for recurrence of sudden cardiac arrest. N Engl J Med. 1986;314:271-273.
15. Davis MJ, Hockings BE, el Dessouky MA, Hajar HA, Taylor RR. Cigarette smoking and ventricular arrhythmia in coronary heart disease. Am J Cardiol. 1984;54:282-285.
16. Goldbourt U, Behar S, Reicher-Reiss H, et al, for the Bezafibrate Infarction Prevention Study Group, Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinical manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol. 1993;71:909-915.
17. The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. Circulation. 2000;102:21-27.
18. Klein LW, Ambrose J, Pichard A, Holt J, Gorlin R, Teichholz LE. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol. 1984;3:879-886.
19. Nicod P, Rehr R, Winniford MD, Campbell WB, Firth BG, Hillis LD. Acute systemic and coronary hemodynamic and serologic response to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. J Am Coll Cardiol. 1984;4:964-971.
20. Alfred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med. 1989;321:1426-1432.
21. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther. 1997;2:291-298.
22. Oparil S. Pathophysiology of sudden coronary death in women: implications for prevention. Circulation. 1998;97:2103-2105.
23. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282.
24. Wang H, Shi H, Wang Z. Nicotine depresses the functions of multiple cardiac potassium channels. Life Sci. 1999;65:PL143-PL149.
25. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
26. Antiarrhythmics Versus Implantable Defibriilators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
27. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
28. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation. 1998;97:1514-1521.